ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,839, issued on Aug. 25, was assigned to INTRABIO LTD. (London).
"Branched-chain amino acid derivatives to treat disease" was invented by Grant Charles Churchill (Oxford, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds represented by Formula I:and the pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, and R3 are as defined as set forth in the specification. The present disclosure also provides compounds having Formula I for use to treat or prevent the progression of a lysosomal storage disorder or a neurodegenerative disease in a subject, provide neuroprotection in a subject ...